The Technology
The heart of our solution is an analyser that uses lasers to verify IV drug identity and concentration. The components of that service will include the analyser, delivery consumables and a cloud-based library of drug data, as well as anonymised patient data. Our first market application is the verification of oncology drugs in compounding pharmacies.
Veriphi’s bench-top analyser is our first commercial solution and uses lasers to recognise the unique spectral signature for each IV drug compound at specific concentrations. At the same time, our software compares the recorded drug signature to that of a known library of drugs to determine whether the drug is what the clinician intended. If not, the analyser raises an alarm, protecting the patient. Veriphi’s solution can reduce injury, isolate problem areas and create greater transparency for IV medication delivery.
PATENTS
8 granted US patents
22 granted global patents
COMPLIANCE
International Electrotechnical Commission (IEC) approvals complete
PARTNERS
The University of Auckland, School of Pharmacy and School of Medical Science; Dodd-Walls Centre for Photonic and Quantum Technologies
